A team of Nason Yeager attorneys headed by the SEC department head, Michael D. Harris, Esq. represented Aspen Group, Inc. (“Aspen”) in two recent financing transactions that recently closed.
In the first transaction, Aspen sold 2,450,015 shares at $7.15 per share to Canaccord Genuity LLC as sole book runner in a confidentially marketed public offering under Aspen’s existing shelf registration statement. This transaction closed on Jan. 22. Harris was assisted in that financing by SEC partner, Brian S. Bernstein, Esq. and SEC associate, Constantine X. Christakis, Esq.
In the second transaction, two existing lenders agreed to re-finance their existing $10 million of term loans due in Sept. 2020 in exchange for three-year convertible notes convertible at $7.15 per share. The financing closed on Jan. 23. Harris was the principal attorney in connection with loan financing assisted by lending partner, Alan I. Armour, Esq.
In the second public offering, on Feb. 3 Cocrystal Pharma, Inc. (Nasdaq COCP) sold 3,492,063 shares of common stock at $0.63 per share in a registered direct offering under Cocrystal’s existing shelf registration statement. A. G. P./Alliance Global Partners acted as sole placement agent. Harris led a team consisting of Bernstein and associates, Elizaveta Ivanova, Esq. and Christakis.